Magna Ease Versus Trifecta Early Hemodynamics: A Systematic Review and Meta-analysis

Area of Science:

• Cardiology
• Cardiac Surgery
• Biomedical Engineering

Background:

• Aortic valve replacement (AVR) is a common procedure for severe aortic stenosis.
• Stented bioprosthetic valves are widely used, with Magna/Magna Ease and Trifecta being leading options.
• Comparative data on early echocardiographic outcomes of these specific valves are crucial for clinical decision-making.

Purpose of the Study:

• To compare the early echocardiographic outcomes of AVR using Magna/Magna Ease versus Trifecta stented bioprosthetic valves.
• To evaluate differences in hemodynamic performance and early mortality between these two valve types.

Main Methods:

• A systematic search of MEDLINE and EMBASE databases was conducted up to 2017.
• A random-effects meta-analysis included two RCTs and nine observational studies (2119 patients).
• Primary outcome was mean gradient; secondary outcomes included effective orifice area and in-hospital mortality.

Main Results:

• The Magna/Magna Ease valve was associated with a higher early mean gradient (MD = 4.09 mmHg, P < 0.0001).
• Smaller effective orifice area was observed with Magna/Magna Ease (MD = -0.30 cm², P < 0.0001).
• No significant difference in 30-day mortality was found between the two valve groups (RR = 1.01, P = 1.0).

Conclusions:

• The Trifecta valve may provide a modest hemodynamic advantage over the Magna/Magna Ease valve.
• Early mortality rates were comparable between the two stented bioprosthetic valves.
• Long-term studies are needed to ascertain if observed hemodynamic differences impact clinical outcomes.